PureHealth Posts AED 1.8 Billion Nine-Month Profit, Up 14.1% Year on Year

PureHealth Holding PJSC reported a 14.1% year-on-year increase in net profit to 1.8 billion United Arab Emirates dirhams (AED) for the nine months ended September 30, 2026, as group revenue rose 11.5% to AED 22.4 billion, according to the company’s results announcement published on October 30, 2026.

The Abu Dhabi-based group, which describes itself as the largest healthcare group in the Middle East, said group EBITDA increased 20.4% year-on-year to AED 4.2 billion, with the EBITDA margin expanding to 18.6% from 17.3% in the prior-year period. The announcement, datelined Abu Dhabi on October 29, 2026, attributed the performance to the expansion of its international Care platform, increased patient activity across its UAE network and revenue growth in its Cover insurance business.

The Abu Dhabi Securities Exchange, where the company is listed, posted the group’s Financial Results, Board of Directors Report and Management Discussion and Analysis Report for the period ended September 30, 2026 on October 30, 2026, according to the exchange’s financial reports page for the company. The interim condensed consolidated financial statements, presented in UAE dirhams rounded to the nearest thousand, provide the filed figures behind the announcement.

The filed interim consolidated statement of profit or loss shows the following for the nine-month periods:

For the standalone third quarter, the filing shows revenue of AED 7,570,751 thousand against AED 6,527,172 thousand a year earlier, profit for the period of AED 533,013 thousand against AED 521,575 thousand, and profit attributable to owners of AED 518,761 thousand against AED 520,819 thousand. The statements were approved by the Board of Directors and authorised for issue on October 29, 2026. Ernst & Young’s review report, dated October 29, 2026 and conducted under International Standard on Review Engagements 2410, concluded that nothing had come to its attention causing it to believe the statements were not prepared, in all material respects, in accordance with IAS 34, while noting that a review does not express an audit opinion.

Care and Cover Segment Performance

International Care revenue increased 53% year-on-year to AED 7.3 billion and segment EBITDA grew 63% to AED 1.6 billion, with the EBITDA margin expanding to 22.3% from 20.8% a year earlier, the company said. The consolidation of Hellenic Healthcare Group (HHG) in Greece and Cyprus contributed AED 2.3 billion in revenue, Circle Health Group in the UK recorded 5.3% revenue growth supported by a shift towards higher-acuity inpatient activity, and HHG recorded a 6% increase in patient volumes driven primarily by outpatient activity. International operations contributed approximately 33% of group revenue, and the filed geographic split shows revenue outside the UAE of AED 7,361,205 thousand for the nine months, against AED 4,810,100 thousand in the prior-year period. PureHealth completed its EUR 800 million acquisition of a majority stake in HHG in the third quarter of 2025, recognising financial contributions from October 1, 2025, in a transaction that added 11 hospitals and 23 diagnostic centres, according to the company’s prior-year results announcement.

UAE Care reported revenue of AED 8.7 billion, down 9.2% year-on-year, which the company attributed to Unified Purchasing Programme revenue recognition, internal revenue eliminations and lower patient activity during the first quarter; on a normalised basis, revenue increased 6% to AED 10.1 billion. Outpatient volumes increased 9% and inpatient volumes rose 13% across the nine months, operational bed capacity expanded to 3,543 beds from 3,433 in the prior-year period, and bed occupancy increased to 76%. Segment EBITDA increased 3% year-on-year to AED 1.74 billion, with the margin expanding to 20.0% from 17.7%.

Insurance revenue rose 11.7% year-on-year to AED 6.4 billion, supported by policy renewals, pricing discipline and new business growth, according to the announcement. Gross Written Premium grew 14% to AED 6.8 billion, insured members increased 2% to approximately 3.4 million, and health claims processed grew 6% to 43.2 million. Daman’s Property & Casualty business generated AED 166 million in Gross Written Premium during the period following product expansion, strategic partnerships and the launch of a dedicated SME business line, and Daman’s net profit increased 3.9% year-on-year to AED 667 million. The filed segment note records insurance services revenue of AED 6,079,972 thousand and insurance segment net profit of AED 666,888 thousand. Moody’s (MCO ) Ratings assigned Daman an A1 Insurance Financial Strength Rating with a stable outlook, which the company described as the highest such rating assigned by Moody’s to a UAE insurer.

Balance Sheet, Borrowings and Dividend

Total assets stood at AED 57,346,314 thousand at September 30, 2026, with total equity of AED 19,316,819 thousand and total liabilities of AED 38,029,495 thousand, the filed statement of financial position shows. Cash and bank balances were AED 4,212,423 thousand, against AED 7,705,950 thousand at December 31, 2025, and cash generated from operating activities was AED 701,211 thousand, against AED 1,694,441 thousand in the prior-year period.

Borrowings totalled AED 3,232,634 thousand at September 30, 2026. During the period the group entered a new facility agreement of AED 85,553 thousand (EUR 20,056 thousand) bearing interest at six-month EURIBOR plus a margin of 1.80% per annum to finance the construction and subsequent operation of a wind power project, and utilised the remaining AED 106,890 thousand (EUR 25,058 thousand) of existing loan facilities for working capital. The group also acquired a histopathology business and a sterilization business from third parties for purchase consideration of AED 7,941 thousand, recognising a provisional bargain purchase gain of AED 8,518 thousand.

On April 2, 2026, shareholders approved a cash dividend equivalent to 30% of the group’s 2025 profit attributable to owners of the company, amounting to AED 600,632 thousand, or 5.41 fils per share, which was paid during the period, the filing states.

Chairman H.E. Kamal Al Maazmi said the performance “reflects the strength of our strategy to build a more diversified healthcare group with a growing international presence,” pointing to the HHG integration in Greece and Cyprus and the continued development of Circle Health Group in the UK. Group Chief Executive Officer Shaista Asif said the group is embedding AI and digital technologies into its businesses “from clinical pathways to procurement and patient engagement,” and cited Circle Health Group’s agreement to take over selected UK laboratory operations from Unilabs Limited. According to the announcement, that agreement creates a diagnostic platform with two dedicated hub laboratories in London, supported by a network of licensed laboratories across the UK and serving more than 90 external healthcare clients.

Among operational updates in the announcement, the Department of Health – Abu Dhabi designated SEHA Sheikh Tahnoon Bin Mohammed Medical City as a Centre of Excellence for Stroke, SEHA Tawam Hospital launched the UAE’s first certified Low-Dose Radiotherapy programme, and Sheikh Shakhbout Medical City received Magnet Recognition from the American Nurses Credentialing Center, becoming the second hospital in the UAE to achieve the designation, while surpassing 1,200 robotic-assisted surgical procedures since launching its programme in 2020.

PureHealth said it expects international Care to remain a key growth driver as the HHG integration matures, Circle develops higher-acuity services and bolt-on acquisitions deepen scale. In the UAE, the group said it remains focused on patient activity, higher capacity utilisation, specialised and complex care and operational improvements, while Daman focuses on strengthening its health insurance position and scaling its Property & Casualty offering. Capital allocation will remain selective, the company said, balancing organic investments, value-accretive mergers and acquisitions, and shareholder returns.